Dynavax Technologies Corp. Daily Stock Analysis

Daily Stock Analysis, DVAX, Dynavax Technologies Corp, priceseries

Dynavax Technologies Corp. Daily Stock Analysis
Stock Information
Open
10.18
Close
9.87
High
10.55
Low
9.76
Previous Close
10.46
Daily Price Gain
-0.59
YTD High
14.84
YTD High Date
Jan 11, 2022
YTD Low
9.76
YTD Low Date
Mar 7, 2022
YTD Price Change
-4.01
YTD Gain
-28.89%
52 Week High
21.39
52 Week High Date
Nov 4, 2021
52 Week Low
7.09
52 Week Low Date
May 11, 2021
52 Week Price Change
1.37
52 Week Gain
16.12%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 24. 2017
4.05
Mar 14. 2017
5.76
12 Trading Days
42.11%
Link
LONG
Jun 1. 2017
5.65
Jul 5. 2017
9.63
23 Trading Days
70.41%
Link
LONG
Aug 30. 2017
17.20
Sep 26. 2017
20.60
18 Trading Days
19.78%
Link
LONG
Sep 28. 2017
21.25
Oct 12. 2017
22.41
10 Trading Days
5.44%
Link
LONG
Mar 20. 2018
17.45
Apr 2. 2018
18.84
8 Trading Days
7.99%
Link
LONG
Jan 4. 2019
9.81
Jan 23. 2019
11.05
12 Trading Days
12.67%
Link
LONG
Aug 7. 2019
2.99
Aug 27. 2019
4.15
14 Trading Days
38.80%
Link
LONG
Oct 21. 2019
4.27
Nov 7. 2019
4.98
13 Trading Days
16.61%
Link
LONG
Apr 27. 2020
3.89
Apr 28. 2020
4.09
1 Trading Days
5.27%
Link
LONG
May 14. 2020
4.20
May 22. 2020
5.13
6 Trading Days
22.34%
Link
LONG
Jun 18. 2020
6.13
Jul 10. 2020
8.66
15 Trading Days
41.30%
Link
LONG
Jul 14. 2020
9.19
Jul 22. 2020
9.82
6 Trading Days
6.83%
Link
LONG
Oct 12. 2020
4.64
Oct 14. 2020
4.94
2 Trading Days
6.36%
Link
LONG
Jan 22. 2021
5.22
Feb 18. 2021
9.57
18 Trading Days
83.43%
Link
LONG
Mar 9. 2021
9.14
Mar 24. 2021
9.93
11 Trading Days
8.63%
Link
LONG
Aug 3. 2021
9.74
Aug 18. 2021
11.83
11 Trading Days
21.50%
Link
LONG
Aug 20. 2021
12.04
Sep 10. 2021
17.70
14 Trading Days
47.01%
Link
LONG
Sep 22. 2021
18.79
Sep 27. 2021
19.88
3 Trading Days
5.77%
Link
Company Information
Stock Symbol
DVAX
Exchange
NasdaqCM
Company URL
http://www.dynavax.com
Company Phone
5108485100
CEO
Eddie J. Gray
Headquarters
California
Business Address
2929 SEVENTH STREET, SUITE 100, BERKELEY, CA 94710
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001029142
About

Dynavax Technologies Corp. is a clinical-stage biopharmaceutical company that uses toll-like receptor biology to discover and develop novel vaccines and therapeutics. The company's development programs are organized under its three areas of focus: vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. The company's other products under pipeline are SD-101, DV1179 Autoimmune Disease and AZD1419 Asthma Therapy. Dynavax Technologies was founded by Lawrence M. Lichtenstein, Dennis A. Carson and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

Description

Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. The company's lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies. Its product candidates also comprise AZD1419, which is in Phase II clinical trial for the treatment of asthma; DV230F that is in preclinical stage for the treatment of liver tumors; and DV1001, a TLR 7&8 agonist, which is in preclinical stage for the treatment of for multiple malignancies, as well as DV281 for the treatment of non-small cell lung cancer. It has collaboration and license agreements with AstraZeneca AB to develop AZD1419 for the treatment of asthma; and Merck & Co. to develop SD-101 for varios immuno-oncology therapies. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading